Skip to main content

Pragati India Fund sells 15% stake in PTC; Sterlite Power offloads over 14% units in IndiGrid

 PTC Industries share price was locked in 20 percent upper circuit on August 14 at Rs 582.50

 

Sponsor Sterlite Power Grid Ventures has offloaded 14.65 percent units of KKR and Singapore's GIC-backed India Grid Trust via open market transactions on August 14.

Private power transmission company Sterlite Power Grid has sold 8,55,07,569 units (representing 14.65 percent of total outstanding units) at Rs 98 per unit, bulk deals data available on the NSE showed. As per shareholding pattern available on exchanges at the end of June, Sterlite Power held 15 percent (8,75,48,026 units) in the company.


India Grid is an infrastructure investment trust (InvIT) established to own inter-state power transmission assets in India. IndiGrid was established in October 2016 by sponsor Sterlite Power Grid Ventures.

Larsen & Toubro was the leading buyer in this deal, acquiring 2,55,09,897 units (representing 4.37 percent of total outstanding units) at Rs 98 per unit.

Danske Invest India Fund, Societe Generale and Morgan Stanley Asia Singapore acquired 30,75,408,  89,71,074 and  38,17,044 units in India Grid at Rs 99.02, Rs 98 each, respectively.

Among other deals, Vikas Vijaykumar Khemani, the Founder of Carnelian Asset Management, acquired 27,000 shares (representing 0.51 percent of its total paid-up equity) in casting and machine components manufacturer PTC Industries at Rs 533.46 per share on the BSE. Well-known investor Porinjuv Veliyath also bought 27,000 shares at Rs 469.52 per share.

Mona Russell Mehta bought 4.5 lakh shares in PTC Industries at Rs 453.01 per share and Pankaj Prasoon And (HUF) acquired 63,000 shares at Rs 453.60 per share.

However, Pragati India Fund was the seller in PTC Industries, selling 7,85,913 equity shares (representing 15 percent of total paid-up equity) at Rs 453.74 per share. As of June, Pragati India Fund held 20 percent stake in the company.

PTC Industries share price was locked in 20 percent upper circuit on August 14 at Rs 582.50.

Plutus Wealth Management has bought 14.85 lakh shares in HeidelbergCement India at Rs 191.72 per share on the NSE.

KKR India Financial Services has offloaded 70.5 lakh shares in CG Power and Industrial Solutions (or 1.12 percent of total paid up equity) at Rs 13.56 per share on the BSE.


KKR India had held 8.10 percent stake (5,07,36,588 equity shares) in CG Power as of June 30.

Adesh Ventures sold 7,87,863 shares in Man Industries at Rs 60.36 per share on the NSE

Trishashna Holdings & Investments Pvt bought 3,94,835 RE shares in Satin Creditcare at Rs 23.5 per share, whereas UTI Mutual Fund - Banking Sector Fund (UT163) sold 1,08,533 RE shares at Rs 26.06 per share on the NSE.

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...
Post a Comment
Read more

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...
Post a Comment
Read more